2018 ICPE Presentation: Minor Differences, Major Consequences? Lessons Learned from Replication of a Claims-Based Drug Safety Assessment

Project Title	2018 ICPE Presentation: Minor Differences, Major Consequences? Lessons Learned from Replication of a Claims-Based Drug Safety Assessment
Date	Wednesday, August 22, 2018
Location	Minor Differences, Major Consequences? Lessons Learned from Replication of a Claims-Based Drug Safety Assessment
Medical Product	dabigatran warfarin
Health Outcome	acute myocardial infarction (AMI) myocardial infarction
Host	34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Authors	Ting-Ying Jane Huang, Laura Hou, Laura Shockro, Ella Pestine, Michael Nguyen, Judith C. Maro, Rima Izem
Related Assessments	Abstracts of the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Prague Congress Centre, Prague, Czech Republic, August 22–26, 2018 \| Abstract 365 A Protocol for Assessment of Dabigatran and Selected Safety Outcomes Outcomes of Dabigatran and Warfarin for Atrial Fibrillation in Contemporary Practice: A Retrospective Cohort Study
Publication Type	Presentation

Search form